staurosporine has been researched along with ferruginol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, J; Connelly, M; González, MA; Rivas, F | 1 |
| Connelly, M; Fatima, I; Gautam, LN; González, MA; Ling, T; Miranda-Carboni, G; Rivas, F; Tran, M; Wood, RK | 1 |
| Bassett, R; Dea-Ayuela, MA; González-Cardenete, MA; Hamulić, D; Hering, S; Loza-Mejía, MA; Padrón, JM; Rivas, F; Stadler, M | 1 |
3 other study(ies) available for staurosporine and ferruginol
| Article | Year |
|---|---|
Antimalarial activity of abietane ferruginol analogues possessing a phthalimide group.
Topics: Abietanes; Animals; Antimalarials; CHO Cells; Cricetinae; Cricetulus; Hep G2 Cells; Humans; Phthalimides; Plant Extracts; Plasmodium falciparum | 2014 |
(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Products; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Female; Humans; MCF-7 Cells; Molecular Structure; Stereoisomerism; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2015 |
Synthesis and Biological Studies of (+)-Liquiditerpenoic Acid A (Abietopinoic Acid) and Representative Analogues: SAR Studies.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Diterpenes; Humans; Leishmania; Molecular Docking Simulation; Molecular Structure; Species Specificity; Structure-Activity Relationship | 2019 |